Top 3 ASX 200 Stocks with Promising Upside Potential

The following ASX 200 stocks have promising potential because they are backed by strong earnings and lucrative business models which position them well for future value creation.

Lovisa Holdings Limited (ASX: LOV)

Lovisa Holdings Limited (ASX: LOV) is one of the best ASX 200 stocks with promising upside as it has a market capitalisation of $2.46 billion and current annual dividend yield of 3.6%.

The company in the first half of FY2026 reported strong results as underlying revenue rose 22.7% to $498.1 million while underlying EBIT increased 20.4% to $109.1 million.

The company opened 85 new stores during the half which increased its network to 1,095 stores across more than 50 markets while it also invested in upgraded store formats and digital capabilities while operating cash flow rose 30.3% from the prior corresponding period to $183.8 million.

Underlying gross margin also improved by 50 basis points to 82.9% which reflects operating leverage and disciplined execution.

Management reported a solid start to the second half as total sales increased 21.5% while comparable store sales rose 1.6% over the first seven weeks. The company also expects this momentum to continue through global store expansion which is supported by a strong balance sheet.

Sonic Healthcare Limited (ASX: SHL)

Sonic Healthcare Limited (ASX: SHL) is one of the ASX 200 stocks with promising potential and has a current market capitalisation of approximately $10.4 billion along with a current annual dividend yield of 5.14%.

Recent developments included the integration of the LADR laboratory acquisition in Germany together with the expansion of advanced diagnostics in the US while the company secured new pathology and hospital contracts in the UK along with capital management initiatives such as a planned $450–500 million Brisbane laboratory sale and leaseback and potential share buy-backs.

The company in the first half of FY2026 reported revenue of $5.45 billion which increased 17% while EBITDA rose 10% to $907 million.

Cash generated from operations increased 10% to $682 million while earnings per share improved 8% because of 5% organic revenue growth and stronger operating leverage.

Management maintained FY2026 guidance and expects EBITDA of $1.87–1.95 billion while the company is focused on cost control and margin expansion across its global businesses.

The a2 Milk Company Limited (ASX: A2M)

The a2 Milk Company Limited (ASX: A2M) is one of the top ASX 200 stocks with promising potential. It has a current market capitalisation of approximately $5.04 billion and a current annual dividend yield of 6.65% which will give investors exposure to a premium dairy and infant nutrition company.

The company in 1H FY2026 reported strong financial results as revenue increased 18.8% to NZ$993.5 million while EBITDA rose 18.4% to NZ$155.0 million and NPAT increased 9.4% to NZ$112.1 million.

Recent developments include the completion of the strategic a2 Pokeno acquisition along with a NZ$300 million fully franked special dividend after key China regulatory approvals. 

Management expects FY2026 revenue of approximately NZ$1.97 billion with the EBITDA margin at the high end of the 14.0% to 14.5% range and NPAT slightly higher than FY2025. The company will also provide detailed FY2027 guidance with its audited results in August.

(Source: Company Announcements)